Autolus Therapeutics (AUTL) Enterprise Value (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Enterprise Value came in at -$300.7 million in Q4 2025, up 48.86% YoY from -$202.0 million in Q4 2024, and up 18.16% on a QoQ basis from -$367.4 million in Q3 2025.
Autolus Therapeutics (AUTL) Enterprise Value (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Enterprise Value data on file, last reported at -$300.7 million in Q4 2025.
- Quarterly Enterprise Value rose 48.86% year-over-year to -$300.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$300.7 million (up 48.86% YoY) and the FY2025 annual result came in at -$300.7 million, up 48.86% from the prior year.
- Enterprise Value grew to -$300.7 million in Q4 2025, from -$367.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$163.4 million in Q3 2022 to a low of -$759.5 million in Q1 2024.
- A 5-year average of -$373.6 million and a median of -$309.3 million in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value plunged 39426.21% — and 2025, when it jumped 48.86%.
- Tracing AUTL's Enterprise Value over 5 years: stood at -$310.7 million in 2021, then decreased by 23.2% to -$382.8 million in 2022, then surged by 37.21% to -$240.3 million in 2023, then tumbled by 144.67% to -$588.0 million in 2024, then jumped by 48.86% to -$300.7 million in 2025.
- The last three Enterprise Value figures came in at -$300.7 million (Q4 2025), -$367.4 million (Q3 2025), and -$454.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | -201.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -201.63 Mn |
| Dec 31, 2025 | -300.71 Mn |
| Sep 30, 2025 | -367.42 Mn |
| Jun 30, 2025 | -454.33 Mn |
| Mar 31, 2025 | -516.60 Mn |
| Dec 31, 2024 | -588.02 Mn |
| Sep 30, 2024 | -658.54 Mn |
| Jun 30, 2024 | -706.96 Mn |
| Mar 31, 2024 | -759.54 Mn |
| Dec 31, 2023 | -240.34 Mn |
| Sep 30, 2023 | -256.85 Mn |
| Jun 30, 2023 | -307.83 Mn |
| Mar 31, 2023 | -343.36 Mn |
| Dec 31, 2022 | -382.76 Mn |
| Sep 30, 2022 | -163.37 Mn |
| Jun 30, 2022 | -216.76 Mn |
| Mar 31, 2022 | -268.89 Mn |
| Dec 31, 2021 | -310.68 Mn |
| Sep 30, 2021 | -173.27 Mn |
| Jun 30, 2021 | -216.56 Mn |